IBB - 2 Best Biotech Stocks to Buy in January
In the past 12 months, two of the best-performing biotech stocks were cancer immunotherapy firm Fate Therapeutics (NASDAQ: FATE) and German coronavirus vaccine manufacturer BioNTech (NASDAQ: BNTX) . During this period, Fate Therapeutics and BioNTech have nearly tripled or quadrupled investors' money. That kind of return is spectacular, considering that the industry benchmark, the iShares NASDAQ Biotechnology Index (NASDAQ: IBB) , went up by just 44% over in the last 12 months.
Even though both stocks have gone up quite a bit, their rallies are far from finished. Here's why they can continue their momentum and add wealth to your portfolio.
Data source: YCharts .
For further details see:
2 Best Biotech Stocks to Buy in January